4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We investigated the value of circulating tumor DNA (ctDNA) in predicting tumor response to neoadjuvant chemoradiotherapy (nCRT), monitoring tumor burden, and prognosing survival in patients with locally advanced rectal cancer (LARC).

          Related collections

          Author and article information

          Contributors
          Journal
          Clinical Cancer Research
          Clin Cancer Res
          American Association for Cancer Research (AACR)
          1078-0432
          1557-3265
          January 04 2021
          January 01 2021
          January 01 2021
          October 12 2020
          : 27
          : 1
          : 301-310
          Article
          10.1158/1078-0432.CCR-20-2299
          33046514
          7abd5d44-107a-407d-8cb4-54e083d4c1c0
          © 2020
          History

          Comments

          Comment on this article